Utility of oral swab sampling for ebola virus detection in guinea pig model

Emerging Infectious Diseases

Volumn 21, Issue 10, 2015, Pages 1816-1819

  Spengler, Jessica R ^a   Chakrabarti, Ayan K ^a   Coleman McCray, Joann D ^a   Martin, Brock E ^a   Nichol, Stuart T ^a   Spiropoulou, Christina F ^a   Bird, Brian H ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS NUCLEOPROTEIN;

ADULT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; COPY NUMBER VARIATION; DIAGNOSTIC VALUE; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; FEMALE; HYPOTHERMIA; MALE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SENSITIVITY ANALYSIS; VIRUS DETECTION; VIRUS VIRULENCE; ANIMAL; EARLY DIAGNOSIS; GUINEA PIG; HEMORRHAGIC FEVER, EBOLA; HUMAN; MOUTH; PROCEDURES; SPECIMEN HANDLING; VIROLOGY;

ANIMALS; EARLY DIAGNOSIS; EBOLAVIRUS; GUINEA PIGS; HEMORRHAGIC FEVER, EBOLA; HUMANS; MOUTH; SPECIMEN HANDLING;

EID: 84942155217     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2110.150840     Document Type: Article

References (10)

1. Bray M, Davis K, Geisbert T, Schmaljohn C, Huggins J. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis. 1999;179(Suppl 1):S248-58. http://dx.doi.org/10.1086/514292
2. Lupton HW, Lambert R, Bumgardner DL, Moe JB, Eddy GA. Inactivated vaccine for Ebola virus efficacious in guinea pig model. Lancet. 1980;2:1294-5. http://dx.doi.org/10.1016/ S0140-6736(80)92352-1
3. Connolly BM, Steele KE, Davis KJ, Geisbert TW, Kell WM, Jaax NK, et al. Pathogenesis of experimental Ebola virus infection in guinea pigs. J Infect Dis. 1999;179(Suppl 1):S203-17. http://dx.doi.org/10.1086/514305
4. Ebihara H, Zivcec M, Gardner D, Falzarano D, LaCasse R, Rosenke R, et al. A Syrian golden hamster model recapitulating Ebola hemorrhagic fever. J Infect Dis. 2013;207:306-18. http://dx.doi.org/10.1093/infdis/jis626
5. Volchkov VE, Chepurnov AA, Volchkova VA, Ternovoj VA, Klenk HD. Molecular characterization of guinea pig-adapted variants of Ebola virus. Virology. 2000;277 (1):147-55. http://www.ncbi.nlm.nih.gov/pubmed/11062045
6. Chupurnov AA, Chernukhin IV, Ternovoĭ VA, Kudojarova NM, Makhova NM, Azaev MS, et al. Attempts to develop a vaccine against Ebola fever. Vopr Virusol. 1995;40:257-60.
7. Prescott J, Bushmaker T, Fischer R, Miazgowicz K, Judson S, Munster V. Postmortem stability of Ebola virus. Emerg Infect Dis. 2015;21:856-9. http://dx.doi.org/10.3201/eid2105.150041
8. Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis. 2007;196(Suppl 2):S142-7. http://dx.doi.org/10.1086/520545
9. Wong G, Qiu X, Richardson JS, Cutts T, Collignon B, Gren J, et al. Ebola virus transmission in guinea pigs. J Virol. 2015;89:1314-23. http://dx.doi.org/10.1128/JVI.02836-14
10. National Research Council. Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the care and use of laboratory animals. 8th ed. Washington (DC): National Academies Press; 2011.